Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

325 Views

C4. Respiratory infections - viral

Poster Session: Respiratory Infections - Viral

(P-682) The Risk of Cardiorespiratory Events for up to 180 days Following Respiratory Syncytial Virus (RSV) Infection Hospitalization: A Self-controlled Case Series Analysis

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Caihua Liang, MD, PhD

Senior Director
Pfizer Inc
New York, New York, United States

Jennifer Judy, MS, PhD

Director
Pfizer
New York, New York, United States
Negar Aliabadi, MD, MS

Senior Director
Pfizer
New York, New York, United States
RS

Reiko Sato, PhD (she/her/hers)

Senior Director
Pfizer, Inc.
Collegeville, Pennsylvania, United States
EC

Erica Chilson, PharmD

Senior Director, US Medical Affairs
Pfizer
500 Arcola Road, Pennsylvania, United States
YZ

Yun Zhou, Master in science

Associate director & Team leader
Genesis Research Group
Hoboken, New Jersey, United States
XZ

Xin Zhao, MS

Principal Scientist, Biostatistics
Genesis Research Group
Hoboken, New Jersey, United States
BG

Bradford D. Gessner, M.D., M.P.H.

Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States
Elizabeth Begier, MD, M.P.H.

Senior Director, Scientific Affairs Lead, RSV Antiviral/Adult Vaccine Program
Pfizer Vaccines
Dublin, Dublin, Ireland